Sleep characteristics and long-term risk of type 2 diabetes among women with gestational diabetes
Yin X, Bao W, Ley SH, et al.
JAMA Netw Open. 2025;8(3):e250142.
Leggi
Blu
Le Breaking News di colore blu sono relative ad abstract di articoli originali di particolare rilevanza.
Continuous glucose monitoring-based titration of once-weekly insulin icodec in insulin-naive individuals with type 2 diabetes (ONWARDS 9): a phase 3b, multicenter, single-arm, treat-to-target clinical trial
Bergenstal RM, Ásbjörnsdóttir B, Johanning Bari T, et al.
Diabetes Technol Ther. Pub. online 5 Mar 2025.
Leggi
IA-2A positivity increases risk of progression within and across established stages of type 1 diabetes
Sims EK, Cuthbertson D, Ferrat LA, et al.
Diabetologia. Pub. online 28 Feb 2025.
Leggi
A systematic literature review on the burden of diabetic ketoacidosis in type 2 diabetes mellitus
Wysham C, Bindal A, Levrat-Guillen F, et al.
Diabetes Obes Metab. Pub. online 3 Mar 2025.
Leggi
Impact of bodyweight loss on type 2 diabetes remission: a systematic review and meta-regression analysis of randomised controlled trials
Kanbour S, Ageeb RA, Malik RA, Abu-Raddad LJ
Lancet Diabetes Endocrinol. Pub. online 26 Feb 2025.
Leggi
Sex-specific optimal cut-off points for metabolic health indicators to predict incident type 2 diabetes mellitus
Xing Z, Xiao M, Schocken DD, et al.
Nutr Metab Cardiovasc Dis. Pub. online 27 Feb 2025.
Leggi
Sodium-glucose cotransporter-2 inhibitors and arrhythmias: a meta-analysis of 38 randomized controlled trials
Jaiswal V, Ang SP, Kumar D, et al.
JACC Adv. 2025;4(3):101615.
Leggi
Prognostic benefit of GLP-1 RA addition to SGLT2i in patients with ASCVD and heart failure: a cohort study
Chen SY, Wu JY, Liao KM, Lin YM
Eur Heart J Cardiovasc Pharmacother. 2025:pvaf014.
Leggi
The effect of empagliflozin on non-alcoholic fatty liver disease-related parameters in patients with type 2 diabetes mellitus: a randomized controlled trial
Shojaei F, Erfanifar A, Kalbasi S, et al.
BMC Endocr Disord. 2025;25(1):52.
Leggi
Finerenone and outpatient worsening heart failure with mildly reduced or preserved ejection fraction: a secondary analysis of the FINEARTS-HF randomized clinical trial
Cunningham JW, Chatur S, Claggett BL, et al.
JAMA Cardiol. 2025:e250016.
Leggi